Medical Science Liaison, Rare Diseases

Emilia- Romagna Annual Gross Salary: €58.000 – €77.500. This salary range reflects the full-time base salary we expect to offer for this role at the time of posting. The base salary will be determined based on several factors, including, but not limited to, relevant experience and skills acquired in the role. Variable bonus linked to performance...

Role: Medical Science LiaisonContract type: Permanent / Full TimeArea to cover: Emilia-Romagna, Marche, Abruzzo e MoliseResidenza/Domicilio: Emilia- RomagnaCompensation package: Annual Gross Salary: €58.000 – €77.500. This salary range reflects the full-time base salary we expect to offer for this role at the time of posting. The base salary will be...

Overview In this Medical Science Liaison role, you will serve as the scientific bridge between Biogen and external healthcare professionals in the designated Italian regions. You will share up-to-date medical knowledge, gather insights, and support research activities to inform Medical Affairs planning. You will work cross-functionally to ensure compliant...

Biogen Italia seeks a Medical Science Liaison to cover Emilia-Romagna, Marche, Abruzzo and Molise from a dedicated base in Emilia‑Romagna. The MSL provides field-based medical and scientific expertise, builds partnerships with key stakeholders, and supports medical education and data-generation initiatives.The role requires a BSc in a scientific...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. Over three years ago, we embarked on a transformative journey to become a truly global innovative healthcare...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Overview As a field-based Medical Science Liaison, you will be the scientific bridge between IQVIA, investigators, and trial sites across Italy and a broader territory. You will support site engagement, education, and patient recruitment in oncology, delivering credible scientific presentations and resolving medical barriers. You’ll work with site...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri‑complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly...